The global women's health market, valued at $20 billion in 2009, is dominated by the United States, says a new report on women's health from PharmaLive.

January 20, 2011

1 Min Read
Women’s Health Market Valued at $20 Billion

According to the report, the women's healthcare market segment has a strong demand for novel therapeutics and improved diagnostics. Therapeutic categories gaining increased attention within this market include breast cancer, oral contraceptives, hormone therapy for menopause, heart disease, rheumatoid arthritis, and gynecologic infections including STD's and osteoporosis.
 

The report predicts that diagnostic imaging applications showing increasing market potential include bone densitometry, breast biopsy and imaging, OB/GYN ultrasound imaging, and fetal & neonatal monitoring. These disciplines represent almost half of the women's health market segment in terms of cost.

More information is available in Women’s Health Review and Outlook 2011, available at www.pharmalive.com/special_reports 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like